Starpharma Holdings OTC Stock Forecast - Naive Prediction
| SPHRY Stock | USD 2.30 0.00 0.00% |
Starpharma OTC Stock outlook is based on your current time horizon.
At this time, the value of RSI of Starpharma Holdings' share price is approaching 44. This usually implies that the otc stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Starpharma Holdings, making its price go up or down. Momentum 44
Sell Extended
Oversold | Overbought |
It is a matter of debate whether otc price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Starpharma Holdings based on different types of headlines from major news networks to social media. Using Starpharma Holdings hype-based prediction, you can estimate the value of Starpharma Holdings from the perspective of Starpharma Holdings response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Starpharma Holdings on the next trading day is expected to be 1.96 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 4.50. Starpharma Holdings after-hype prediction price | USD 2.3 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as otc price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Starpharma |
Starpharma Holdings Additional Predictive Modules
Most predictive techniques to examine Starpharma price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Starpharma using various technical indicators. When you analyze Starpharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Starpharma Holdings Naive Prediction Price Forecast For the 28th of January
Given 90 days horizon, the Naive Prediction forecasted value of Starpharma Holdings on the next trading day is expected to be 1.96 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.50.Please note that although there have been many attempts to predict Starpharma OTC Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Starpharma Holdings' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Starpharma Holdings OTC Stock Forecast Pattern
| Backtest Starpharma Holdings | Starpharma Holdings Price Prediction | Buy or Sell Advice |
Starpharma Holdings Forecasted Value
In the context of forecasting Starpharma Holdings' OTC Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Starpharma Holdings' downside and upside margins for the forecasting period are 0.02 and 6.20, respectively. We have considered Starpharma Holdings' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Starpharma Holdings otc stock data series using in forecasting. Note that when a statistical model is used to represent Starpharma Holdings otc stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 113.5175 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0738 |
| MAPE | Mean absolute percentage error | 0.0302 |
| SAE | Sum of the absolute errors | 4.5015 |
Predictive Modules for Starpharma Holdings
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Starpharma Holdings. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Starpharma Holdings After-Hype Price Density Analysis
As far as predicting the price of Starpharma Holdings at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Starpharma Holdings or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of OTC Stock prices, such as prices of Starpharma Holdings, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Starpharma Holdings Estimiated After-Hype Price Volatility
In the context of predicting Starpharma Holdings' otc stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Starpharma Holdings' historical news coverage. Starpharma Holdings' after-hype downside and upside margins for the prediction period are 0.12 and 6.54, respectively. We have considered Starpharma Holdings' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Starpharma Holdings is very risky at this time. Analysis and calculation of next after-hype price of Starpharma Holdings is based on 3 months time horizon.
Starpharma Holdings OTC Stock Price Outlook Analysis
Have you ever been surprised when a price of a OTC Stock such as Starpharma Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Starpharma Holdings backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the OTC price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Starpharma Holdings, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.11 | 4.24 | 0.00 | 0.03 | 0 Events / Month | 1 Events / Month | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
2.30 | 2.30 | 0.00 |
|
Starpharma Holdings Hype Timeline
Starpharma Holdings is at this time traded for 2.30. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.03. Starpharma is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is at this time at 0.11%. %. The volatility of related hype on Starpharma Holdings is about 1693.97%, with the expected price after the next announcement by competition of 2.33. The book value of the company was at this time reported as 1.18. The company recorded a loss per share of 0.31. Starpharma Holdings had not issued any dividends in recent years. Assuming the 90 days horizon the next projected press release will be within a week. Check out Historical Fundamental Analysis of Starpharma Holdings to cross-verify your projections.Starpharma Holdings Related Hype Analysis
Having access to credible news sources related to Starpharma Holdings' direct competition is more important than ever and may enhance your ability to predict Starpharma Holdings' future price movements. Getting to know how Starpharma Holdings' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Starpharma Holdings may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IUGNF | Imugene Limited | 0.00 | 0 per month | 6.30 | 0.05 | 25.00 | (13.04) | 47.15 | |
| MSCLF | Satellos Bioscience | 0.00 | 0 per month | 3.10 | 0.18 | 10.42 | (5.88) | 19.61 | |
| PHYOF | IXICO plc | 0.00 | 1 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| PRNAF | Alterity Therapeutics Limited | 11.89 | 2 per month | 0.00 | 0.08 | 0.00 | 0.00 | 81.61 | |
| PBIGF | Paradigm Biopharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.07) | 15.38 | (13.33) | 37.57 | |
| POLBF | Poolbeg Pharma PLC | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BSEM | Biostem Technologies | 0.00 | 0 per month | 5.71 | 0.07 | 17.65 | (9.69) | 39.49 | |
| NICXF | Nicox SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KNTPF | Kintor Pharmaceutical Limited | (0.11) | 8 per month | 0.00 | 0.09 | 0.00 | 0.00 | 27.27 | |
| BIOYF | Biosyent | (9.28) | 1 per month | 1.06 | 0.16 | 3.14 | (1.89) | 9.22 |
Other Forecasting Options for Starpharma Holdings
For every potential investor in Starpharma, whether a beginner or expert, Starpharma Holdings' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Starpharma OTC Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Starpharma. Basic forecasting techniques help filter out the noise by identifying Starpharma Holdings' price trends.Starpharma Holdings Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Starpharma Holdings otc stock to make a market-neutral strategy. Peer analysis of Starpharma Holdings could also be used in its relative valuation, which is a method of valuing Starpharma Holdings by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Starpharma Holdings Market Strength Events
Market strength indicators help investors to evaluate how Starpharma Holdings otc stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Starpharma Holdings shares will generate the highest return on investment. By undertsting and applying Starpharma Holdings otc stock market strength indicators, traders can identify Starpharma Holdings entry and exit signals to maximize returns.
Starpharma Holdings Risk Indicators
The analysis of Starpharma Holdings' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Starpharma Holdings' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting starpharma otc stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.5 | |||
| Semi Deviation | 2.64 | |||
| Standard Deviation | 4.62 | |||
| Variance | 21.33 | |||
| Downside Variance | 31.92 | |||
| Semi Variance | 6.99 | |||
| Expected Short fall | (6.01) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Starpharma Holdings
The number of cover stories for Starpharma Holdings depends on current market conditions and Starpharma Holdings' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Starpharma Holdings is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Starpharma Holdings' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Additional Tools for Starpharma OTC Stock Analysis
When running Starpharma Holdings' price analysis, check to measure Starpharma Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Starpharma Holdings is operating at the current time. Most of Starpharma Holdings' value examination focuses on studying past and present price action to predict the probability of Starpharma Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Starpharma Holdings' price. Additionally, you may evaluate how the addition of Starpharma Holdings to your portfolios can decrease your overall portfolio volatility.